BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11243577)

  • 1. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
    Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
    Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
    Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male/female differences in drug-induced emesis and motion sickness in Suncus murinus.
    Matsuki N; Wang CH; Okada F; Tamura M; Ikegaya Y; Lin SC; Hsu YN; Chaung LJ; Chen SJ; Saito H
    Pharmacol Biochem Behav; 1997 Aug; 57(4):721-5. PubMed ID: 9258999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of a peripheral mechanism in the emesis induced by cardiac glycosides in Suncus murinus.
    Kakimoto S; Saito H; Matsuki N
    Biol Pharm Bull; 1997 May; 20(5):486-9. PubMed ID: 9178926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotonin and anticancer drug-induced emesis].
    Minami M; Endo T; Hamaue N; Hirafuji M
    Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
    Bhandari P; Andrews PL
    Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
    Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
    Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-emetic activity of GK-128 in Suncus murinus.
    Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
    Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
    Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
    Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
    Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
    Ozaki A; Sukamoto T
    Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological review of tropisetron].
    Yokoyama T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):219-26. PubMed ID: 10584235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol-induced emesis in the house musk shrew, Suncus murinus.
    Chen Y; Saito H; Matsuki N
    Life Sci; 1997; 60(4-5):253-61. PubMed ID: 9010480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
    Darmani NA
    J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis.
    Perez EA
    J Clin Oncol; 1995 Apr; 13(4):1036-43. PubMed ID: 7707101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis.
    Tonini M; Candura SM; Messori E; Rizzi CA
    Pharmacol Res; 1995 May; 31(5):257-60. PubMed ID: 7479521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew).
    Ullah I; Subhan F; Lu Z; Chan SW; Rudd JA
    J Pharmacol Sci; 2017 Apr; 133(4):232-239. PubMed ID: 28363413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.